ESPR
Closed
Esperion Therapeutics Inc
1.
0 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.9844
Day's Range: 0.949 - 1.04
Send
sign up or login to leave a comment!
When Written:
1.59
Esperion Therapeutics Inc. is a publicly-traded biopharmaceutical company based in Ann Arbor, Michigan, USA. The company specializes in the development of novel therapies for the treatment of cardiovascular and metabolic diseases. Esperion's lead product candidate is bempedoic acid, a small molecule inhibitor of ATP citrate lyase, which is currently in Phase 3 clinical trials for the treatment of hyperlipidemia and atherosclerosis. The company was founded in 2008 and went public in 2013. Esperion has partnerships with several pharmaceutical companies, including Daiichi Sankyo, Zydus Cadila, and Otsuka Pharmaceutical Co. Ltd.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








